Therefore, the induction of PD-L1 by tumorous IRE1α under ER stress is not the main reason for potentiated anti-tumor capacity of CD8+T cells, but helps to provide the molecular basis for the increase of immunotherapy efficacy. Here, CD8A is linked to neoplasm.